Last reviewed · How we verify
cefazolin or vancomycin
At a glance
| Generic name | cefazolin or vancomycin |
|---|---|
| Also known as | Cefazolin (Ancef), Vancomycin (Vancocin) |
| Sponsor | Brigham and Women's Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Aspartate aminotransferase increased
- Nausea
- Diarrhoea
- Vomiting
- Viral infection
- Rhinitis allergic
- Pyogenic granuloma
- Postoperative splinting
- Neutropenia
- Thrombocytopenia
- Thrombocytosis
- Abdominal pain
Key clinical trials
- IO Vancomycin Spine (PHASE2, PHASE3)
- Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial (PHASE4)
- Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia (PHASE4)
- Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial (PHASE4)
- IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA (NA)
- Antibiotic Concentrations Among Critically Ill Patients
- Staphylococcus Aureus Network Adaptive Platform Trial (PHASE4)
- IO Vancomycin in TSA (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |